← SynDRA
ER-27319
SynDRA canonical compound SYN0086620 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SYK |
|---|
| Mechanism of action | Mediator release inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- SYK INHIBITOR
- Mediator release inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- ABL2
- PAK5
- PAK6
- PASK
- PDGFRA
- PDGFRB
- PDK1
- PDPK1
- PHKG2
- PIM1
- PIM2
- PIM3
- PKN2
- PLK1
- PLK2
- PLK3
- PRKAA1
- PRKACA
- PRKCA
- PRKCB
- PRKCD
- PRKCE
- PRKCG
- PRKCH
- PRKCI
- PRKCQ
- PAK4
- PAK3
- PAK2
- MST1R
- MAPKAPK2
- MAPKAPK3
- MAPKAPK5
- MARK1
- MARK2
- MARK3
- MELK
- MERTK
- MET
Cross-references
Synonyms
- ER-27319 free base
- UNII-5308DT8060
- 9(10H)-Acridinone, 10-(3-aminopropyl)-3,4-dimethyl-
- GTPL9611
- SCHEMBL8660539
- SCHEMBL30862930
- CHEBI:92203
- BDBM50396076
- NCGC00161415-01
- NCGC00161415-02
- NCGC00161415-03
- NCGC00161415-04
- BRD-K11927976-050-01-1
- BRD-K11927976-050-02-9
- er-27319 free base
- SCHEMBL503354
- CS-0173509
- 3,4-dimethyl-10-(3-aminopropyl)-9-acridone oxalate
- T78641
- ER-27319, >=98% (HPLC), solid
- UNII-218W96J218
- RefChem:137443
- orb1944493
- SCHEMBL29356906
- SCHEMBL30421082
- BIA01095
- HY-138961
- DA-73170
Look up ER-27319 in the interactive SynDRA portal →